Altamonte Springs, Fla.-based AdventHealth has launched a pilot program designed to harness AI to assess a patient's risk of developing breast cancer. The Genomics Risk Assessment for Cancer and Early Detection program collects a patient's personal and family medical history, then uses AI to 'overlay' similar anonymous patient records, according to a Sept.

佛罗里达州阿尔塔蒙特斯普林斯市的AdventHealth公司推出了一项试点项目，旨在利用人工智能评估患者患乳腺癌的风险。据9月1日报道，癌症和早期发现基因组学风险评估计划收集患者的个人和家族病史，然后使用人工智能“覆盖”类似的匿名患者记录。

25 news release from AdventHealth.The program is also integrated into the mammogram process to help radiologists analyze patient imaging and determine breast density.If AI detects a patient may have an increased risk of breast cancer, the patient is offered additional opportunities to determine an accurate diagnosis.'In the first two months of using the EMR-embedded AI software, we saw a 23% increase in patients identified as high risk.

25 AdventHealth的新闻稿。该程序还集成到乳房X光检查过程中，以帮助放射科医生分析患者成像并确定乳房密度。如果AI检测到患者患乳腺癌的风险增加，则会为患者提供额外的机会来确定准确的诊断。”在使用EMR嵌入式AI软件的前两个月，我们发现高危患者增加了23%。

This means we were able to navigate them into evidence-based pathways, which can include additional imaging, genetic counseling and genetic testing, in an effort to detect cancer early,' Wes Walker, MD, the health system's director of genomics and personalized health and associate chief medical information officer, told Becker's.The GRACE program provides risk assessment for hereditary cancers, including breast, ovarian and colorectal cancer/Lynch syndrome, and is being used in mammography centers, primary care practices and gastrointestinal clinics.  The first of its kind in Florida, the program launched Aug.

这意味着我们能够将它们引导到循证途径中，其中可以包括额外的成像，遗传咨询和基因检测，以早期发现癌症，”卫生系统基因组学和个性化健康主任兼副首席医学信息官Wes Walker医学博士告诉Becker's。GRACE计划为遗传性癌症（包括乳腺癌，卵巢癌和结直肠癌/林奇综合征）提供风险评估，并正在乳腺X线照相中心，初级保健实践和胃肠道诊所中使用。该计划于8月在佛罗里达州首次推出。

1 at AdventHealth's Winter Park and Waterford Lakes locations, the release said..

1在AdventHealth的冬季公园和Waterford Lakes地点，新闻稿说。。